发明名称 |
Fermented cereal product obtained by fermentation of rye bran with a Lactobacillus curvatus strain |
摘要 |
The present invention refers to a non-antibiotic therapeutic strategy for inhibiting oro-gastro-intestinal infections and pathogens in general and particularly Heliobacter pylori adherence and colonization in the gastrointestinal channel and preventing or relieving associated oro-gastro-intestinal disease. The invention relates to methods and products based on an active cereal product or ferric quinate. The invention is also applicable to other oro-gastro-intestinal pathogens in both humans and animals. |
申请公布号 |
US9357792(B2) |
申请公布日期 |
2016.06.07 |
申请号 |
US200812068971 |
申请日期 |
2008.02.13 |
申请人 |
Borén Thomas;Hallmans Göran;Åman Per |
发明人 |
Borén Thomas;Hallmans Göran;Åman Per |
分类号 |
A61K36/899;A23L1/105;A23K1/00;A23K1/14;A23K1/175;A23K1/18;A23L1/10;A23L1/304;A23L2/52;A61K31/122;A61K33/26;A61K35/744;A61K35/747;C12R1/225 |
主分类号 |
A61K36/899 |
代理机构 |
Bacon & Thomas, PLLC |
代理人 |
Bacon & Thomas, PLLC |
主权项 |
1. A fermented rye bran obtained by fermentation of rye bran with Lactobacillus curvatus strain Lb 14 DSMZ Deposit No. 13890, at 37° C. for about 24 hours, wherein said fermented rye bran is heat treated by heating the fermented rye bran at 100° C. for about 3 hours or by autoclaving at 120° C. for about 20 minutes, and is formulated as a food product suitable for human or animal consumption, and wherein said food product, upon consumption, inhibits the adherence and colonization of oro-gastro-intestinal pathogens (OGIPs) in humans and animals. |
地址 |
Umeå SE |